135P Isunakinra as monotherapy and combined with nivolumab for treatment-resistant advanced solid tumours: Exploratory effect data, tolerability, and pharmacokinetics from a dose escalation trial
C. Becerra, H. Olivecrona, M. de Château, S.A. Paulson
{"title":"135P Isunakinra as monotherapy and combined with nivolumab for treatment-resistant advanced solid tumours: Exploratory effect data, tolerability, and pharmacokinetics from a dose escalation trial","authors":"C. Becerra, H. Olivecrona, M. de Château, S.A. Paulson","doi":"10.1016/j.iotech.2023.100607","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":192507,"journal":{"name":"Immuno-Oncology and Technology","volume":"1 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Immuno-Oncology and Technology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1016/j.iotech.2023.100607","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
